Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290547 · ClinicalTrials.gov registry record · NA
Pilot Study of Multi-wavelength Laser for Tattoo Removal
A NA study of Tattoo Removal, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 2
- Study locations
NCT03290547 is a NA study of Tattoo Removal that has completed, run by Cutera. The registered enrollment target is 22 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03290547, a NA study of Tattoo Removal, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 2
- Study locations
Study Summary
To evaluate the safety and efficacy of an investigational version of the Cutera enLighten laser that offers muliple wavelengths for tattoo removal.
Conditions Studied
Interventions
- DEVICE Cutera enLighten laser
Study Locations (2)
California
- Cutera Research Center - Brisbane
Massachusetts
- Skin Care Physicians - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-07-08 |
| Est. Completion | 2017-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03290547
The ClinicalTrials.gov registry entry for NCT03290547 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cutera, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tattoo Removal appearing as the primary indexed condition, and to 1 intervention - of which Cutera enLighten laser is the first listed.
NCT03290547 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03290547 about?
NCT03290547 is a clinical study titled "Pilot Study of Multi-wavelength Laser for Tattoo Removal". To evaluate the safety and efficacy of an investigational version of the Cutera enLighten laser that offers muliple wavelengths for tattoo removal.
What is the current status of trial NCT03290547?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2015-07-08. Estimated completion is 2017-11-29.
What conditions does trial NCT03290547 study?
This clinical trial studies the following conditions: Tattoo Removal.
What interventions are being tested in trial NCT03290547?
The interventions under investigation include: Cutera enLighten laser (DEVICE).
Who is sponsoring clinical trial NCT03290547?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03290547 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tattoo Removal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.